北交所周报：北证转融券业务暂停，程序化交易监管规定实施效果渐佳

Group 1 - Wuxi Jinghai (836547) focuses on amino acids primarily for the pharmaceutical sector, with applications in food, health products, and cosmetics [1] - The company is making significant progress in expanding its customer base and business, particularly in the overseas pharmaceutical and health product markets, including efforts for EU CFP registration and Japan IP registration [1] - Tress (834014) has repurchased 2.602 million shares, accounting for 2.1% of its total share capital, with a total expenditure of 5.23 million yuan [1] Group 2 - The North Exchange has seen updates from five companies regarding their IPO projects, with four under inquiry and one submitted for registration [2][3] - The North Exchange's overall performance was strong, with the North Certificate 50 index rising by 0.1% as of July 12, 2024, although it lagged behind the ChiNext index by approximately 1.7 percentage points [40][44] - The average market capitalization of companies on the North Exchange is 1.22 billion yuan, significantly lower than the average market capitalization of companies on the ChiNext and Sci-Tech Innovation Board [45][60] Group 3 - Kang Le Wei Shi announced plans to issue up to 108 million overseas listed ordinary shares, marking a significant step in the "North + H" model, which aims to enhance financing channels for companies listed on the North Exchange [7] - The North Exchange's theme funds performed weakly overall, with the Huaxia North Exchange Innovation Small and Medium Enterprises Fund showing a notable increase of approximately 4.4% [14][15] - The North Exchange's trading volume for the week was 13.74 billion yuan, with an average weekly trading amount of 0.55 billion yuan and a turnover rate of 12.91% [43][60]